France· FR:61872390
CANDESARTAN/HYDROCHLOROTHIAZIDE ZYDUS 8 mg/12,5 mg, comprimé
A medicinal product containing hydrochlorothiazide + candésartan cilexétil, registered in France by ZYDUS FRANCE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- HYDROCHLOROTHIAZIDE + CANDÉSARTAN CILEXÉTIL
- Manufacturer
- ZYDUS FRANCE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400926990626plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 30 comprimé(s)EUR 3.75
- cip133400926990916plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 90 comprimé(s)EUR 10.85
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hydrochlorothiazide + candésartan cilexétil in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCANCOMBINOKrka, d.d., Novo mesto, Novo mesto
- FinlandArtican CompTEVA Sweden AB
- SwedenAtacand Plus 16 mg/12,5 mg TablettCheplapharm Arzneimittel GmbH
- GermanyAtacand PlusCheplapharm Arzneimittel Gmbh
- ItalyBLOPRESIDCHEPLAPHARM ARZNEIMITTEL GMBH
- CanadaATACAND PLUSCHEPLAPHARM ARZNEIMITTEL GMBH
- United StatesATACAND HCTANI Pharmaceuticals, Inc.
- NorwayAtacand PlusOrifarm AS
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Atacand Plus, Atacand Plus Mite
- Belgium · Atacand Plus, Candesartan Plus Hct Eg
- Bulgaria · Кандесартан Hct Актавис, Кандестар Н
- Cyprus · Atacand Plus, Candepress Comp
- Czechia · Cancombino, Carzap Hct
- Germany · Atacand Plus, Atacand Plus Forte
- Denmark · Atacand Zid, Candemox Comp
- Estonia · Atacand Plus, Canocombi
- Spain · Atacand Plus, Atacand Plus Forte
- Finland · Atacand Plus, Candemox Comp
- United Kingdom (Northern Ireland) · Candesartan And Hydrochlorothiazide, Candesartan/Hydrochlorothiazide
- Greece · Atacand Plus, Fyronexe Plus®
- Croatia · Karbicombi
- Hungary · Karbicombi
- Ireland · Atacand Plus, Blopress Plus
- Iceland · Candesartan Hct Beta, Candpress Comp
- Italy · Blopresid, Candesartan E Idroclorotiazide Alter
- Lithuania · Candesartan Hct Actavis, Canocombi
- Luxembourg · Atacand Plus, Candesartan Comp Ratiopharm
- Latvia · Canocombi, Carzan Hct
- Malta · Candesartan/Hydrochlorothiazide Aurobindo Pharma (Malta)
- Netherlands · Atacand Plus, Candesartan Cilexetil Hctz Krka
- Norway · Atacand Plus, Atacand Plus Mite
- Poland · Candepres Hct, Carzap Hct
- Portugal · Blopress, Candesartan + Hidroclorotiazida Alter
- Romania · Candesartan Hct Swyssi, Candesartan Hidroclorotiazidă Aurobindo
- Sweden · Atacand Plus, Blopress Comp
- Slovenia · Atacand Plus, Candea Hct
- Slovakia · Atacand Plus, Candesartan Hct Ratiopharm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1045dbe4-8f82-4995-972d-b903f46913c8 GET /v1/drugs/1045dbe4-8f82-4995-972d-b903f46913c8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61872390",
"date_amm": "2013-03-06",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "HYDROCHLOROTHIAZIDE + CANDÉSARTAN CILEXÉTIL",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about hydrochlorothiazide + candésartan cilexétil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.